findmyKOL
Clinical trialNCT01429064CompletedPhase 2Interventional

Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001

SponsorOrion Corporation, Orion PharmaEnrollment76Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Czechia
  • Klinika Onkologie A Radioterapie Lfuk A Fn

    Hradec Králové, Czechia

Estonia
  • East-Tallinn Central Hospital

    Tallinn, Estonia

Finland
  • Helsinki University Central Hospital

    Helsinki, Finland

  • Kuopio University Hospital

    Kuopio, Finland

  • Oulu University Hospital

    Oulu, Finland

  • Tampere University Hospital

    Tampere, Finland

  • Turku University Hospital

    Turku, Finland

France
  • Saint Louis Hospital

    Paris, France

  • Institut Gustave Roussy

    Villejuif, France

United Kingdom
  • Queen Elizabeth Hospital

    Birmingham, United Kingdom

  • Velindre Cancer Centre

    Cardiff, United Kingdom

  • Christie Hospital

    Manchester, United Kingdom

  • Churchill Hospital

    Oxford, United Kingdom

United States
  • the Urology Center of Colorado

    Wheat Ridge, Colorado, United States

  • Eastern Ct Hematology and Oncology Associates

    Norwich, Connecticut, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Carolina Urologic Research Center

    Myrtle Beach, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2011
Primary completion
30 Nov 2015
Completion
30 Nov 2015
Last update posted
20 Feb 2017
Registered enrollment
76
Registry id
NCT01429064

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.